Team Member

Folefac Aminkeng

Folefac Aminkeng

Email: folefac@cmmt.ubc.ca

Biography

Dr. Folefac Aminkeng is a research fellow at the Canadian Pharmacogenomics Network for Drug Safety (CPNDS) – an international multicentre active surveillance and pharmacogenomics consortium; and the Department of Medical Genetics of the University of British Columbia. Folefac obtained his master’s degree and PhD in Human, Molecular and Statistical Genomics from the Vrije Universiteit Brussel in Belgium and joined the CPNDS as a postdoctoral fellow in 2011. His research interests have focused on “pharmacogenomics of adverse drug reactions in oncology” and “pharmacogenomic pharmacoethnicity in clinical therapeutics”. He has made extensive contributions to these fields including the identification of an important gene involved in the development of cardiomyopathy and congestive heart failure after cancer treatment (Aminkeng F et al, Nature Genetics. 2015 Sep;47(9):1079-84). He is the recipient of a number of fellowships including the CIHR Training Program in Bridging Scientific Domains for Drug Safety and Effectiveness, Michael Smith Foundation for Health Research and Child and Family Research Institute Bertram Hoffmeister Postdoctoral Fellowships. He has also been recognized for a distinguished academic and scientific career by a number of awards including the 2015 Golden Helix Top Prize. He is currently a member of several distinguish academic societies including the Canadian Society of Pharmacology and Therapeutics and the American Society of Human Genetics.